Adamis Pharmaceuticals has announced an important addition to its intellectual property with receipt of a notice of allowance of patent claims supporting its cancer immunotherapy portfolio in the US. Notice of allowance is the final step ...
Tags: Cancer Immunology, Cancer, Cancer cure